BioCentury
ARTICLE | Company News

Amorfix, University of Texas MD Anderson Cancer Center deal

May 6, 2013 7:00 AM UTC

Amorfix and the university partnered to research misfolded proteins and identify targets for lung cancer therapeutics. Researchers at the cancer center will use Amorfix's anti-cancer antibodies to ide...